scout
|Videos|October 21, 2017

COMBI-AD and BRIM8 Studies in Melanoma

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses BRAF and MEK inhibitor combinations studies in melanoma.

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses BRAF and MEK inhibitor combinations studies in melanoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME